XTX Topco’s NeuroOne Medical Technologies NMTC Stock Holding History

XTX Topco’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.6K	Sell	7,214 -7,028	-49%	-$33.8K	﹤0.01%	3426
2025 Q4	$64.8K	Buy	14,242 +10,860	+321%	+$49.5K	﹤0.01%	2765
2025 Q3	$18K	Sell	3,382 -9,224	-73%	-$45.2K	﹤0.01%	2348
2025 Q2	$51.3K	Buy	+12,606	New	+$46.5K	﹤0.01%	2010
2025 Q1	–	Sell	-3,087	Closed	-$15.3K	–	2860
2024 Q4	$15.3K	Sell	3,087 -1,314	-30%	-$6.55K	﹤0.01%	2087
2024 Q3	$26.1K	Buy	+4,401	New	+$22K	﹤0.01%	1795

Other funds holding NMTC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

XTX Topco's NMTC Position: Q1 2026 in Review

XTX Topco reduced its NeuroOne Medical Technologies (NMTC) stake by 49% in Q1 2026, selling an estimated $33.8K and leaving 7,214 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3426.

XTX Topco first reported a position in NMTC in Q3 2024 and has held it in 6 quarters since. The position peaked at $64.8K in Q4 2025. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

XTX Topco held 7,214 shares of NeuroOne Medical Technologies worth $33.6K as of Q1 2026.
XTX Topco sold 7,028 NeuroOne Medical Technologies shares in Q1 2026, an estimated $33.8K.
NeuroOne Medical Technologies made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3426 holding.
XTX Topco first reported a position in NeuroOne Medical Technologies in Q3 2024 and has held it in 6 quarters since.
XTX Topco's NeuroOne Medical Technologies position peaked at $64.8K in Q4 2025.
32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.